Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22
Phase 31

Trial Status

Completed1
Recruiting1
Terminated1

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT05376319Phase 2Terminated
PR3-AAV Resilient Remission or PRRR
ANCA Associated VasculitisGranulomatosis With PolyangiitisMicroscopic Polyangiitis
PrincipalinvestigatorStart date: 2023-06-30
NCT00104299Phase 2/3Completed
Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
Microscopic PolyangiitisVasculitisWegener's Granulomatosis
Studychair
NCT07556484Phase 1Recruiting
Pharmacokinetics Of Emulsified Avacopan Applied By NG Tube
Antineutrophil Cytoplasmic Antibody Positive VasculitisDiffuse Alveolar Hemorrhage
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

John H. Stone, MD, MPH

Johns Hopkins University

Moderately Similar
2 trials

Shared therapeutic areas:

Granulomatosis with PolyangiitisMicroscopic PolyangiitisVasculitis

Worked with same sponsors:

Genentech, Inc.Immune Tolerance Network (ITN)+1 more
Collaborated on 1 trial
Similarity Score34%

Peter A Merkel, MD, MPH

University of Pennsylvania

Related
10 trials

Shared therapeutic areas:

Granulomatosis with PolyangiitisVasculitisMicroscopic Polyangiitis+1 more
Similarity Score20%

Jeffrey P Krischer, PhD

University of South Florida

Related
3 trials

Shared therapeutic areas:

Granulomatosis with PolyangiitisAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisVasculitis
Similarity Score15%

Peter Merkel, MD, MPH

University of Pennsylvania

Related
4 trials

Shared therapeutic areas:

Microscopic PolyangiitisVasculitisGranulomatosis with Polyangiitis
Similarity Score15%

Juhong Shi, M.D

Peking Union Medical College Hospital

Related
8 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisGranulomatosis with PolyangiitisMicroscopic Polyangiitis
Similarity Score15%

Peter A. Merkel, MD, MPH

University of Pennsylvania

Related
10 trials

Shared therapeutic areas:

Granulomatosis with PolyangiitisMicroscopic PolyangiitisVasculitis
Similarity Score15%

Amanda M. Terry, MA

University of South Florida College of Medicine

Related
2 trials

Shared therapeutic areas:

Microscopic PolyangiitisGranulomatosis with Polyangiitis
Similarity Score10%

Peter A. Merkel, MD, MPH

Boston University

Related
2 trials

Shared therapeutic areas:

Granulomatosis with PolyangiitisMicroscopic Polyangiitis
Similarity Score10%

Peter C. Grayson, MD

Boston University

Related
2 trials

Shared therapeutic areas:

Microscopic PolyangiitisGranulomatosis with Polyangiitis
Similarity Score10%

Carlo Buzio, MD

University of Parma

Related
3 trials

Shared therapeutic areas:

Microscopic PolyangiitisGranulomatosis with Polyangiitis
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05376319Phase 2PrincipalInvestigator

PR3-AAV Resilient Remission or PRRR

ANCA Associated VasculitisGranulomatosis With PolyangiitisMicroscopic Polyangiitis
Terminated
NCT00104299Phase 2/3StudyChair

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis

Microscopic PolyangiitisVasculitisWegener's Granulomatosis
Completed
NCT07556484Phase 1PrincipalInvestigator

Pharmacokinetics Of Emulsified Avacopan Applied By NG Tube

Antineutrophil Cytoplasmic Antibody Positive VasculitisDiffuse Alveolar Hemorrhage
Recruiting

All 3 trials loaded